Search Results

Cost-effectiveness of sacituzumab govitecan versus chemotherapy in advanced or metastatic triple-negative breast cancer.

• Authors : Lang, Yitian; Chai, Qingqing; Tao, Wenqi

Subjects: TRIPLE-negative breast cancer; COST effectiveness; MEDICAL care costsUNITED States

• Source: Breast; Apr2023, Vol. 68, p173-180, 8p

Record details

Investigators at Merck & Company Discuss Findings in Breast Cancer (Systemic Therapy, Survival and End-of-life Costs for Metastatic Triple-negative Breast Cancer: Retrospective Seer-medicare Study of Women Age >= 65 Years).

• Source: Women's Health Weekly. 2021, pages. 36

Record details

A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care.

• Authors : Eriksson, Mikael; Destounis, Stamatia; Czene, Kamila

Subjects: TOMOSYNTHESIS; BREAST; BREAST cancerUNITED States

• Source: Science Translational Medicine; 5/11/2022, Vol. 14 Issue 644, p1-10, 10p

Record details

Hologic: Medicare Insurance Coverage for Breast Cancer Index Test Expanded to Include Node-Positive Breast Cancer.

• Source: Contify Life Science News. 2021.

Record details

Unique Breast Cancer Screening Disparities in a Safety-Net Health System.

• Authors : Allar BG; Center for Surgery and Public Health, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Subjects: Medicare* ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/diagnosis; Humans

• Source: American journal of preventive medicine [Am J Prev Med] 2024 Mar; Vol. 66 (3), pp. 473-482. Date of Electronic Publication: 2023 Oct 14.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8704773 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Does Medicare-eligible high-risk breast cancer screening MRI target the right women?

• Authors : Lo, Glen^1,2,3,4 (AUTHOR) ; McLaughlin, Aden¹ (AUTHOR); Jacques, Angela^5,6 (AUTHOR)

Subjects: *BREAST cancer; *EARLY detection of cancer; *WOMEN'S rightsGAINESVILLE (Fla.); PERTH (W.A.); WESTERN Australia

• Source: Journal of Medical Imaging & Radiation Oncology. Apr2020, Vol. 64 Issue 2, p220-228. 9p.

Record details

Medicare Announced Insurance Coverage for Breast Cancer Index.

• Source: Plus Company Updates. 2021.

Record details

Costs of breast cancer recurrence after initial treatment for HR+, HER2-, high-risk early breast cancer: estimates from SEER-Medicare linked data.

• Authors : Vitko AS; Value, Evidence, and Outcomes (VEO) - Oncology, Eli Lilly and Company, Indianapolis, IN, USA.; Martin P

Subjects: Medicare* ; Breast Neoplasms*; Female

• Source: Journal of medical economics [J Med Econ] 2024 Jan-Dec; Vol. 27 (1), pp. 84-96. Date of Electronic Publication: 2023 Dec 19.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Out-of-Pocket Cost Modeling of Adjuvant Radiation Therapy Duration in Standard-of-Care Early Stage Breast Cancer Treatment Across Medicaid and Medicare Plans.

• Authors : Wu VS; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio.; Khlopin M

Subjects: Medicare* ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/radiotherapy; Aged

• Source: Practical radiation oncology [Pract Radiat Oncol] 2024 Jan-Feb; Vol. 14 (1), pp. 24-27. Date of Electronic Publication: 2023 Sep 24.Publisher: Elsevier Country of Publication: United States NLM ID: 101558279 Publication Model: Print-Electronic Cited Medium:

Record details

Cost sharing for breast cancer hormone therapy: How do dual eligible patients' copayment impact adherence

• Authors : Ma, Siyu; Shepard, Donald S.; Ritter, Grant A.

• Source: PLoS ONE. May 18, 2021, Vol. 16 Issue 5, e0250967

Record details